12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Company News  |  Deals

Valeant Pharmaceuticals, Bausch + Lomb deal

Valeant completed its acquisition of ophthalmic company Bausch + Lomb for $8.7...

Read the full 37 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >